Name | Pladienolide B |
---|---|
Supplier | Tocris Bioscience |
Catalog | 2024 |
Prices | $329.00 |
Sizes | 500 µg |
Function Type | Inhibitor |
Cas Number | 445493-23-2 |
Chemical Name | (4R,7R,8S,9E,11S,12S)-8-(Acetyloxy)-4,7-dihydroxy-12-[(1E,3E,5S)-6-[(2R,3R)-3-[(1R,2S)-2-hydroxy-1-methylbutyl]-2-oxiranyl]-1,5-dimethyl-1,3-hexadien-1-yl]-7,11-dimethyloxacyclododec-9-en-2-one |
Formula | C30H48O8 |
Molecular Weight | 536.7 |
Purity | >95 % |
Description | mRNA splicing inhibitor; decreases splicing capacity up to 75% in vitro . Directly targets splicesome-associated 130 (SAP130), inhibits splicing factor 3B subunit (SF3B1) and impairs U2 small nuclear ribonucleoprotein (U2 snRNP) interaction with pre-mRNA. Arrests cell cycle in G 1 and G 2/M phases. Displays antitumor activity against gastric cancer cells (IC 50 values are 1.6-4.9 nM). Cell permeable and active in vivo . |
Supplier Page | Shop |
Tuohy VK, Lu Z, Sobel RA, Laursen RA, Lees MB. J Immunol. 1989 Mar 1;142(5):1523-7.
Sobel RA, Tuohy VK, Lu ZJ, Laursen RA, Lees MB. J Neuropathol Exp Neurol. 1990 Sep;49(5):468-79.
Kuchroo VK, Sobel RA, Yamamura T, Greenfield E, Dorf ME, Lees MB. Pathobiology. 1991;59(5):305-12.